Since proteomic and genomic analysis implicated the FAK pathway as a potential driver of the functional effects of breast cancer EVs, we hypothesized that inhibition of the FAK signaling pathway using a validated inhibitor (PF-573.228) may reduce EV-induced breast cancer cell invasion. The gene discussed is PTK2; the disease is breast carcinoma.